Role of DR5 and DcR1 in 5-FU apoptotic response of human colon carcinoma cells

被引：0
|
作者：
Granci, V. [1 ]
Campigna, E. [1 ]
Gongora, C. [1 ]
Ychou, M. [1 ]
Martineau, P. [1 ]
Del Rio, M. [1 ]
机构：
[1] CRLC Val Aurelle, Batiment Res, Montpellier, France
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70198-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
193
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [1] Apoptosis-related Factors (TRAIL, DR4, DR5, DcR1, DcR2, Apoptotic Cells) and Proliferative Activity in Ameloblastomas
    Rizzardi, Clara
    Leocata, Pietro
    Ventura, Luca
    Zweyer, Marina
    Brollo, Alessandro
    Schneider, Manuela
    Melato, Mauro
    ANTICANCER RESEARCH, 2009, 29 (04) : 1137 - 1142
  • [2] Hypermethylation of DcR1, DcR2, DR4, DR5 gene promoters and clinical significance in tongue carcinoma
    Zhou, Yong
    Zheng, ShuCan
    Luo, QingHua
    Huang, Xuyao
    Zhou, Yong
    Li, ZhaoHui
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2019, 40 (06)
  • [3] Preparation and characterization of a set of monoclonal antibodies to TRAIL and TRAIL receptors DR4, DR5, DcR1, and DcR2
    Liu, XS
    Zhu, Y
    Han, WN
    Li, YN
    Chen, LH
    Jia, W
    Song, CJ
    Liu, F
    Yang, K
    Li, Q
    Jin, BQ
    HYBRIDOMA AND HYBRIDOMICS, 2003, 22 (02): : 121 - 125
  • [4] TRAIL及其受体DR5、DcR1在宫颈癌中的表达
    褚静
    荆亚茹
    贾敏
    现代肿瘤医学, 2009, 17 (09) : 1749 - 1751
  • [5] TRAIL受体DR5、DcR1在宫颈癌组织中的表达
    彭慧霞
    曲群
    尉春艳
    山西医科大学学报, 2012, 43 (09) : 690 - 692
  • [6] Protective effect of TRAIL against proinflammatory cytokines on pancreatic beta cells correlated with decrease in DR5 and increase in DcR1 expressions
    Yilmaz, O.
    Sanlioglu, A. D.
    FEBS JOURNAL, 2016, 283 : 247 - 247
  • [7] Biomarkers of 5-FU response in colon cancer
    Mariadason, John M.
    Tebbutt, Niall C.
    CANCER BIOLOGY & THERAPY, 2011, 11 (08) : 771 - 772
  • [8] CELLULAR BASIS FOR THE INEFFICACY OF 5-FU IN HUMAN-COLON CARCINOMA
    DREWINKO, B
    YANG, LY
    CANCER TREATMENT REPORTS, 1985, 69 (12): : 1391 - 1398
  • [9] TRAIL受体DR4、DR5、DcR1在结肠癌中的表达及意义
    王雪平
    罗玉贤
    马亮亮
    顾福杭
    赫建平
    陈娟
    河北医药, 2011, 33 (14) : 2090 - 2091
  • [10] ORAL 5-FLUOROURACIL (5-FU) AS AN ADJUVANT TO SURGERY IN CARCINOMA OF COLON
    HARVEY, H
    BADDER, E
    DEMUTH, W
    NAHRWOLD, D
    PATTERSON, L
    RICCI, J
    SHAVER, W
    WHITE, D
    LIPTON, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 314 - 314
12345